2026-01-14
Share
- Date:01/10/2025
- Time:2–6 PM
- Address:Gurney Bay Hotel
- Consulting Phone:
+60 10-898 8919
- Date:01/10/2025
- Time:2–6 PM
- Address:Gurney Bay Hotel
- Consulting Phone:
+60 10-898 8919
- Date:01/11/2025
- Time:2–6 PM
- Address:Wisma MCA
- Consulting Phone:
+60 10-898 8919
- Date:01/11/2025
- Time:2–6 PM
- Address:Wisma MCA
- Consulting Phone:
+60 10-898 8919
- Date:01/12/2025
- Time:7–10 PM
- Address:Berjaya Waterfront Hotel
- Consulting Phone:
+60 10-898 8919
- Date:01/12/2025
- Time:7–10 PM
- Address:Berjaya Waterfront Hotel
- Consulting Phone:
+60 10-898 8919
Three-City Lecture Tour in Malaysia: Face-to-Face with Oncology Experts to Explore New Anti-Cancer Paths
When facing cancer, many patients and their families often share the same questions:
Are there any treatment options other than traditional surgery and chemotherapy?
How can one make a more rational and suitable decision for their own condition among different treatment plans?
From January 10th to 12th, 2026,Lin Jing, the Director of the International Oncology Department at Modern Cancer Hospital Guangzhou, will personally visit three cities in Malaysia—Penang, Kuala Lumpur, and Johor Bahru—to hold a public lecture titled “Sharing Session on Minimally Invasive Techniques for Cancer Prevention and Treatment.” She will engage in face-to-face communication with local patients and their families, sharing cutting-edge international concepts and clinical experiences in minimally invasive tumor treatment.
* It is recommended that patients or their family members bring the latest examination reports (pathology reports, CT, MRI, PET-CT, etc.) to allow the professor to evaluate treatment options and costs.
* During the event, patients who have successfully fought cancer will share their experiences with everyone.
* If you are unable to attend the on-site event, you can also visit the Kuala Lumpur/ Penang International Service Center anytime for on-site consultations.

2.Specializes in comprehensive treatments such as minimally invasive targeted therapy, immunotherapy, chemotherapy, radiotherapy, and endocrine therapy for solid tumors including breast cancer, esophageal cancer, stomach cancer, colorectal cancer, liver cancer, lung cancer, and gynecological cancers.
3.Proficient in various minimally invasive treatments such as interventional therapy, argon-helium cryoablation, and radiofrequency ablation, as well as the prevention of tumor complications and the diagnosis and management of critical conditions.





















